Skip to content

Treatment of Anal Fissure by Durvadi Taila Ointment

Effect of Durvadi Taila Malahara in the treatment of Parikartika - A Randomized Controlled Trial

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/01/048852
Enrollment
64
Registered
2023-01-10
Start date
Unknown
Completion date
Unknown
Last updated
2023-02-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K602- Anal fissure, unspecified

Interventions

None listed

Sponsors

Dr Vaishnavi Haridas Hande
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Clinically diagnosed patients of Fissure in ano (Parikartika) Patients irrespective of gender, religion, occupation, educational status and socio-economic status.

Exclusion criteria

Exclusion criteria: I. Bleeding Disorder like Hemophilia etc. II. Patient with uncontrolled systemic disease as like diabetes mellitus and hypertension. III. Patient with Carcinoma of Rectum. IV. Severely immune compromised Patients like AIDS, Tuberculosis. V. Patient having Parikartika secondary to Ulcerative colitis, Syphilis, Crohnâ??s disease. VI. Patient with severe spasm.

Design outcomes

Primary

MeasureTime frame
To evaluate the effect of Durvadi Taila Malahara local application in healing of wound and reducing burning pain in Parikartika ( Fissure in ano )Timepoint: follow up on 7th, 14th, 21st day

Secondary

MeasureTime frame
To evaluate the effect of Durvadi Taila Malahara local application in reducing Gudgata Raktastrava ( PR bleeding) and Anal sphincter Spasm in Parikartika ( Fissure in ano)Timepoint: follow up on 7th, 14th, 21st day

Countries

India

Contacts

Public ContactDr Vaishnavi Haridas Hande

Shri Ayurved Mahavidyalay

drjyoti.dalal@gmail.com9975830051

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026